Grapow, Martin T R; Carrel, Thierry P; Eckstein, Friedrich S (2011). [Surgical treatment options in end-stage heart failure]. Therapeutische Umschau, 68(2), pp. 95-102. Bern: Huber 10.1024/0040-5930/a000126
Full text not available from this repository. (Request a copy)Despite significant improvements in pharmacological therapy heart failure is still one of the leading causes for death in the Western World. The gold standard treatment of end-stage heart failure remains cardiac transplantation, but there is a great excess of eligible candidates compared with the low number of suitable donor organs. The variety of surgical organ preserving treatment strategies has significantly increased during the last 20 years, intenting either to delay or even to prevent the need for cardiac transplantation. An individually tailored surgical concept should be considered as an alternative in any heart failure patient who has reached the limits of pharmacologic therapy. This article gives an overview about current and potential future therapeutic options in end-stage heart failure.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Heart Surgery |
UniBE Contributor: |
Carrel, Thierry |
ISSN: |
0040-5930 |
Publisher: |
Huber |
Language: |
German |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:20 |
Last Modified: |
27 Feb 2024 14:29 |
Publisher DOI: |
10.1024/0040-5930/a000126 |
PubMed ID: |
21271540 |
URI: |
https://boris.unibe.ch/id/eprint/6612 (FactScience: 211608) |
Actions (login required)
 |
Edit item |